1. Home
  2. Analysis
  3. Fondaparinux-sodium
  4. Torsemide

Fondaparinux sodium and Torsemide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fondaparinux sodium and Torsemide. Common interactions include abnormal behaviour among females and renal failure acute among males.

The phase IV clinical study analyzes what interactions people who take Fondaparinux sodium and Torsemide have. It is created by eHealthMe based on reports of 8 people who take Fondaparinux sodium and Torsemide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

8 people who take Fondaparinux sodium and Torsemide together, and have interactions are studied.

What is Fondaparinux sodium?

Fondaparinux sodium has active ingredients of fondaparinux sodium. eHealthMe is studying from 842 Fondaparinux sodium users for its effectiveness, alternative drugs and more.

What is Torsemide?

Torsemide has active ingredients of torsemide. It is often used in high blood pressure. eHealthMe is studying from 23,904 Torsemide users for its effectiveness, alternative drugs and more.

Number of Fondaparinux sodium and Torsemide reports submitted per year:

Fondaparinux sodium and Torsemide drug interactions.

Common Fondaparinux Sodium and Torsemide drug interactions by gender *:

female:

  1. Abnormal behaviour
  2. Anaemia
  3. Cognitive disorder
  4. Cytomegalovirus infection
  5. Deep vein thrombosis
  6. Klebsiella infection
  7. Neutrophil toxic granulation present
  8. Peripheral sensory neuropathy
  9. Pulmonary embolism
  10. Pyrexia

male:

  1. Renal failure acute
  2. Rhabdomyolysis
  3. Dehydration
  4. Diarrhoea
  5. Dizziness
  6. Drug intolerance
  7. Dyspnoea
  8. Ear pain
  9. Fall
  10. Fatigue

Common Fondaparinux Sodium and Torsemide drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Renal failure acute
  2. Rhabdomyolysis
  3. Peripheral sensory neuropathy
  4. Pulmonary embolism
  5. Pyrexia
  6. Traumatic haematoma
  7. Urinary incontinence
  8. Septic shock
  9. B-cell lymphoma
  10. Cytokine release syndrome

* Approximation only. Some reports may have incomplete information.

Do you take Fondaparinux sodium and Torsemide?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Fondaparinux sodium and Torsemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Torsemide side effects:

Browse all side effects of Torsemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Fondaparinux sodium interactions:

Browse all interactions between Fondaparinux sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Torsemide interactions:

Browse all interactions between Torsemide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fondaparinux sodium and torsemide (the active ingredients of Fondaparinux sodium and Torsemide, respectively), and Fondaparinux sodium and Torsemide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Fondaparinux sodium and Torsemide.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.